How many types of COVID-19 vaccines are in development?

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus has afflicted millions of people worldwide. This global crisis has spurred dozens of vaccine development efforts by drug companies, universities and governments.
Around 150 vaccines were in various stages of development across the globe as of mid December 2020; many had completed the Phase III clinical trials, a final step leading to approval by governments around the world.
These vaccines will hit the market once the United States Food and Drug Administration (U.S. FDA) confirms their effectiveness and safety.
Full approval is not necessary to start distributing promising vaccines; the FDA has granted the Pfizer-BioNTech vaccine an emergency use authorization (EUA). The first doses of this vaccine for vaccinating individuals aged 16 years and above began US distribution in mid-December 2020, and the following vaccines were expected to soon follow:
How do COVID-19 vaccines work?
The COVID-19 vaccine helps your body fight the virus by training and tempering the immune system, strengthening your own biological defenses to repel the viral invaders in case you are exposed accidentally.
These are called immune responses to vaccination and are as follows:
- The white blood cells type-T (T cells) identify and kill the virus (cellular immunity).
- The white blood cells type-B (B cells) make antibodies (proteins) to neutralize the virus.
The vaccine trains your white blood cells to recognize the virus well before it starts multiplying inside your body. It also teaches both the T and B cells to retain infection memory, providing a lasting immunity.
As more and more people get vaccinated, the rate of active infections will shrink, leading to fewer infected people shedding virus in each community. This will help protect even those people who are yet to be vaccinated, a concept called herd immunity.
Herd immunity may develop without a vaccine as a critical mass of people are infected through community spread of the virus. They either clear the virus or die, slowly increasing a group’s overall immunity to infection until the virus stops spreading altogether.
This scenario costs many more lives than artificially inducing herd immunity through mass vaccination. Most health authorities around the globe endorse some combination of social distancing, masking and mass-vaccination to reduce the number of new infections.
The various types of COVID-19 vaccines in development are as follows:
- Inactivated virus vaccine: In this technique, the vaccine is manufactured using an inactivated or weakened virus. This weak virus does not cause disease, but it is sufficient to generate an immune response.
- Live attenuated viruses: A genetically weakened (harmless) version of the COVID-19 virus is manufactured inside a lab to make the vaccine. A healthy body generates an immune response to the weak virus. In the process, the white blood cells memorize the viral structure, allowing your body to mount a stronger immune response in the event you are exposed to the actual infection.
- Vaccines using the recombinant proteins: These vaccines use a protein shell that mimics the COVID-19 viral structure. Immune response mounted against this shell works against the live COVID-19 virus, too.
- Vaccines using vectors: Vector vaccines use a common cold virus as a vector (carrier). The code for a COVID-19-specific protein is inserted inside this virus. Once the vector is inside our cells; it releases the “code” inside our body. This code guides our cells to make the COVID-19-specific protein, triggering a strong immune response by white cells.
- DNA vaccines: This vaccine uses a lab grown bacteria to produce genetically engineered DNA that codes for a spike protein. This protein is specific to the COVID-19 virus. When injected, our cells read the DNA template for spike protein, inducing mass production of the protein. The protein sparks an immune response via white cells, preparing them to fight off a coronavirus infection.
- mRNA vaccines: This is a cutting-edge technique using a genetically engineered messenger RNA (mRNA that takes the message from the DNA to the protein-making machinery in the cell) that codes for the COVID-19 specific protein. When injected, this mRNA provides our cells instructions to make the COVID-19 specific protein, which in turn makes the white cells mount an immune response. The Pfizer-BioNTech vaccine uses this technology.
Most of the COVID-19 vaccines consist of two shots given intramuscularly. The first shot is to start building protection. A second shot boosts the level of the protection. As of mid-December 2020, it was unclear how long the immunity conferred by the vaccines will last.
Further adding to logistical challenges in distributing millions of doses, all the vaccines are temperature-sensitive, and maintaining a proper storage is extremely important to maintain their potency. Refrigerated transport and storage is necessary at all levels of the supply chain.
What are the different vaccines available against COVID-19?
The following vaccines are in final stages of development and will hit the market in early 2021. Other contenders in Stage II will be out in the latter half of 2021. Those are not mentioned in this list.
Vaccine name | Vaccine type | Injection Schedule | Licensed for use in | Efficacy |
---|---|---|---|---|
BNT162b2 (BioNTech and Pfizer) | mRNA vaccine | Two doses 21 days apart | UK, Canada, and Bahrain | 95% at Day 7 following the second dose |
mRNA 1273 (Moderna) | (mRNA) vaccine | Two doses 30 days apart | Under FDA review | 94.1% at or after Day 14 following the second dose |
NVX-CoV 2373 (Novavax) | Recombinant protein vaccine | Two doses 21 days apart | Still in Phase III studies | Under research |
ChAdOx1 nCoV-19/AZD1222 (University of Oxford, AstraZeneca, the Serum Institute of India) | Vector vaccine | Two doses 28 days apart; single dose schedule being considered | Still in Phase III studies | 62-70.4% efficacy at or after Day 14 following the second dose |
Ad26.COV2.S (Janssen) | Vector vaccine | Single dose schedule being considered | Under FDA review | Under evaluation |
Ad5-based COVID-19 vaccine (CanSino Biologics | Vector vaccine | Single dose schedule being considered | China for limited use by the military | Unknown |
Sputnik V (Gamaleya Institute) | Vector vaccine, using two separate vector viruses for Doses 1 and 2 | Two doses 28 days apart | Russia | 91.4% based on only 39 cases |
BBIBP-CorV (Sinopharm) | Inactivated vaccine | Two doses 28 days apart | United Arab Emirates | Around 86% |
CoronaVac (Sinovac) | Inactivated vaccine | Two doses 28 days apart | China, limited use | Unknown |
NOTE: Efficacy, in this table, is calculated as preventing symptomatic COVID-19 after the second dose
As the research evolves, we will be able to make informed decisions about which vaccine is best suited for each country and region’s climate, viral strains and particular public health challenges.
Until then, hand washing, social distancing, and masks are the greatest protection against the virus.
Can COVID-19 Vaccines Cause Bell's Palsy?
Four cases of Bell’s palsy were reported among the Pfizer and BioNTech vaccine study in mid December 2020, according to the Food and Drug Administration (FDA). All four cases were in the group that received the vaccine and not the placebo, though that number of cases is not more than would be expected in the general population.
The FDA is monitoring vaccine recipients for evidence of new cases of Bell’s palsy.
Health News
- Attachment Theory: What It Is, Stages & the Different Attachment Styles
- Gentle Parenting: What It Is, Techniques & Discipline
- U.S. Nursing Homes Fail to Report Many Serious Falls, Bedsores: Study
- The Younger You Get Diabetes, the Higher Your Risk for Dementia Later
- FDA Grants Full Approval to Paxlovid to Treat COVID-19
More Health News ยป
Summary
Around 150 vaccines were in various stages of development across the globe as of mid December 2020; many had completed the Phase III clinical trials, a final step leading to approval by governments around the world. Full approval is not necessary to start distributing promising vaccines; the US FDA granted the Pfizer-BioNTech vaccine an emergency use authorization (EUA) in December. Bell's palsy, a facial nerve problem, and allergic reaction were rare but possible side effects of the first vaccine, but their connection to the medication was unclear as of late 2020.
Multimedia: Slideshows, Images & Quizzes
-
Rosacea, Acne, Shingles, Covid-19 Rashes: Common Adult Skin Diseases
Learn to spot and treat skin conditions commonly found in adults such as acne, Covid-19 rashes, eczema, shingles, psoriasis,...
-
Novel Coronavirus (COVID-19) Prevention Quiz
Why is coronavirus considered dangerous? What are the symptoms you should look for? Take this COVID-19 prevention quiz to learn...
-
Coronavirus COVID-19 Prevention: Test Your Medical IQ
What's really the best way to prevent the spread of new coronavirus COVID-19? Should wear a mask or not? Take this quiz to find...
-
COVID-19 Coronavirus Disease: Articles of Interest
Read about COVID-19 Coronavirus Disease. See interesting articles related to vitamins and supplements to boost immunity,...
-
Coronavirus COVID-19 (SARS-CoV-2) Pandemic Outbreak: What You Need to Know
A new strain of coronavirus (COVID-19, SARS-CoV-2) was reported from Wuhan, China in December, 2019. This outbreak of respiratory...
-
What Drugs May Fight COVID-19? Drug Trials, Treatments, Vaccines
What drugs could help fight coronavirus COVID-19? Clinical studies are ongoing for antiviral drugs like hydroxychloroquine,...
Related Disease Conditions
-
COVID-19 vs. Flu vs. Cold
When you're feeling sick, it can be difficult to distinguish the symptoms of a COVID-19 infection from the symptoms of the common cold or the flu (influenza). While fever is common with the flu and COVID-19, sneezing is typically only associated with colds. Though sore throats are typical with colds, they are uncommon with COVID-19 infections and the flu.
-
How Long Does Headache Last With COVID-19?
Headache is a potential symptom of COVID-19 and can also occur after getting vaccinated. COVID-19 headaches typically last for a few days, although the duration depends on your age, immune system, and overall health condition. In mild cases of COVID-19, headaches will usually resolve within a few days. However, in more severe cases, mild or moderate headaches may come and go for up to 90 days.
-
COVID-19 (Coronavirus, 2019-nCoV)
Infection with COVID-19 (2019 novel coronavirus, 2019-nCoV) causes respiratory problems in humans. Transmission of COVID-19 occurs mainly through contact with respiratory sections from an infected person, however, fecal contamination may also spread the virus. Symptoms start off flu-like and progress to coughing, fever, shortness of breath, shaking chills, headache, loss of sense of taste and/or smell, muscle pain, and sore throat. Treatment focuses on supportive care and symptom relief. COVID-19 vaccines are available.
-
How Long Is a COVID-19 Patient Contagious?
People infected with COVID-19 can still be contagious even when they stop feeling sick, so precautionary measures should continue for at least 2 weeks after symptoms disappear and until the COVID-19 test result is negative. Ideally, patients should be quarantined at home or an institution for 2 weeks after the symptoms completely disappear.
-
Can Diarrhea Be an Initial Symptom of COVID-19?
COVID-19 has become a common illness that affects many people. Learn the signs of COVID-19, what causes it, how doctors diagnose it, and what you can do to treat it.
-
COVID-19 vs. Allergies
Though there is some overlap in allergy and COVID-19 signs and symptoms there are also significant differences. Symptoms that they have in common include headache, fatigue, tiredness, shortness of breath, wheezing, and sore throat. Fever does not occur with allergies but is one of the defining symptoms of COVID-19 infections.
-
What Are the Two Crucial Signs of Anaphylaxis?
Anaphylaxis is defined as a group of symptoms exhibited by the body in reaction to a particular substance. Anaphylaxis is a potentially life-threatening reaction and therefore must be promptly spotted and treated.
-
COVID-19 (Coronavirus) Prevention Tips
COVID-19 is a novel coronavirus that spreads from person to person via infected respiratory droplets. The main symptoms of COVID-19 infection include cough, fever, and shortness of breath. Occasionally, people infected with COVID-19 may experience diarrhea, a sore throat, a runny or stuffy nose, or aches and pains. Avoiding contact with infected people, social distancing, not touching your face, frequent hand washing, cleaning, and disinfecting of frequently touched surfaces can help to reduce your risk of contracting the 2019 novel coronavirus.
-
How Long Does Immunity Last After You Get Moderna, Pfizer, or Johnson & Johnson COVID-19 Vaccines?
People's bodies all respond differently to the vaccines so to understand how long immunity lasts, it comes down to your body’s antibody production.
-
Does COVID-19 Affect My Heart?
As per the American Heart Association, COVID-19 may have a long-term effect on the heart. Having a heart condition doesn't make a person more likely to catch COVID-19, but an individual with heart disease or a serious heart condition is more likely to become severely ill from COVID-19 and has a higher risk of death.
-
Should You Take the COVID-19 Vaccine if You Are Trying to Get Pregnant?
The COVID-19 vaccine is still being offered to women who are pregnant or are trying to get pregnant. Current information says that there is no reason not to get vaccinated if you are pregnant or are trying to get pregnant.
-
How Should I Prepare My Kids That Are Going Back to School During COVID-19?
As you start preparing your kids for back to school during COVID-19, there are some ways like wearing a mask and handwashing that can help keep them safe and healthy.
Treatment & Diagnosis
- Wuhan Coronavirus FAQs
- Coronavirus COVID-19 Prevention FAQs
- What if I get COVID-19 with Rheumatoid Arthritis?
- What Are Monoclonal Antibody Treatments for COVID-19 Coronavirus?
- Testing Is Key to COVID-19 Recovery for Patients and Economy
- Should I Go to the Dentist During the COVID-19 Pandemic?
- Is the Test for COVID-19 Coronavirus Reliable?
- How Long Can the COVID-19 Coronavirus Survive?
- What if I get COVID-19 with Diabetes?
- What if I Get COVID-19 with Asthma?
Medications & Supplements
Prevention & Wellness
- COVID Vaccine Is Safe for Kids Who Got Rare Complication of COVID Illness
- COVID Vaccine More Effective Than Infection at Preventing Death, Hospitalization
- COVID Vaccine Boosts Protection, Even After Prior Infection: Study
- Pfizer to Charge $100 Per COVID Shot in 2023
- COVID Vaccine Myths Drive Low Rates of Uptake Among U.S. Kids
- Smoggy Air Could Worsen COVID, Even If You're Vaccinated
- Japan to Drop COVID Restrictions, Ease Entry for Tourists
- More Batches of Moderna COVID Shots Shipped Amid Reports of Shortages
- First Needle-Free COVID Vaccines Get OK in India, China
- COVID Vaccine Won't Raise Stroke Risk
- Less Than Half of Parents Want COVID Vaccine for Youngest Kids
- CDC Backs COVID Vaccine From Novavax
- Changes in Menstrual Cycle Can Come After COVID Shot
- Novavax COVID Vaccine: Alternative to mRNA
- Vaccinations Cut U.S. COVID Deaths by 58 Percent
- COVID Vaccines Saved 20 Million Lives Worldwide in First Year
- COVID Shots For Kids Under 5 Ready, CDC
- FDA Advisors Back Novavax COVID Shot
- High Rates of COVID Vaccination Among Adults With Autism
- FDA Limits J&J COVID Vaccine Due to Blood Clots
- Could Obesity Blunt the Response to the COVID Vaccine?
- Early Promise for COVID Vaccine Taken as Pill
- Only 1 in 5 Parents Plan to Get COVID Vaccine for Kids Under 5 When Available: Survey
- Heart Inflammation Very Rare After COVID Vaccination
- Common COVID Drug Might Be Useful at Lower Dose
- Free COVID Tests, Treatments for Uninsured Americans Cut for Lack of Funding
- About 1 in 6 U.S. Couples Disagrees on COVID Vaccination
- One Big Motivator to Get COVID Vaccine: Travel
- Allergic Reaction to Your First COVID Shot? Risk of Another Is Low
- COVID Vaccine Is a Big Stress-Reliever, Too: Study
- COVID Vaccine in Pregnancy Guards Against Infection in Newborns
- Is the Next Great COVID Vaccine an Inhaled One?
- Beyond Antibodies: Vaccines Teach T-Cells to Fight COVID Long Term
- Vaccination Plus Prior Infection Best Defense Against COVID
- COVID Vaccine May Change Menstrual Cycle
- Study Finds Delta Somewhat Resistant to Vaccines — What About Omicron?
- Federal Court Backs Stay on COVID Vaccine Mandate
- What Parents Should Know About the COVID-19 Vaccine For 5- to 11-Year-Olds
- FDA Panel Supports Moderna Booster Shot
- U.S. Appeals Panel Backs New York City's Vaccine Mandate
- FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
- Lower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company Says
- COVID Death 11x More Likely for Unvaccinated
- White House Issues Tough New Vaccine Mandates
- White House Pushes for More Vaccine Mandates
- COVID-19 Vaccines Boost Antibodies, Even in People With Weak Immune Systems
- Vaccine Power Against COVID Hospitalization Fades in Elderly
- COVID Vaccine Protection Against Severe Disease
- 'Dream Vaccine' for All COVID Variants
- Rise in Breakthrough COVID Infections Among Vaccinated
- US Sees Big Spike in COVID Vaccinations
- COVID Vaccination Required for Most Foreign Visitors to US
- New Data Shows the Power of COVID Vaccines
- Return to Masks Indoors for Vaccinated in Some Areas of US
- Parents Divided on COVID Vaccination for Kids Under 12
- CDC Advisors to Discuss 3rd COVID Vaccine Dose for Immunocompromised
- 'Urgent Threat' of COVID Vaccine Misinformation
- COVID Antibodies From Vaccination Are 3 Times Higher Than From Infection
- Vaccine Effectiveness and Third COVID Booster Shot
- Will We Need a COVID Booster Shot?
- 99% of New COVID Deaths Are Unvaccinated
- Low COVID Vaccination Rates for Seniors in 11 States a 'Powder Keg'
- Do mRNA Vaccines Harm Male Fertility?
- Will We Need a Yearly COVID Booster Vaccine?
- The Real-World Power of Pfizer, Moderna COVID Vaccines
- 'Mix & Match' COVID Vaccine Approach in Testing
- With Increase in Vaccine Acceptance, Herd Immunity by Summer
- When Will You Need a COVID Vaccine Booster Shot?
- New Mask Guidance Brings Challenges, Problems
- FDA Approves COVID Vaccine for Ages 12 to 15
- COVID and Obesity More Deadly for Men Than Women
- New Goal of Vaccinating 70% of Americans by July 4
- COVID Vaccine for Ages 12 and Up
- Will America Reach Herd Immunity?
- Is an Antiviral Pill to Ease COVID Severity on the Way?
- U.S. to Share Up to 60 Million Doses of AstraZeneca Vaccine
- Millions Have Missed Second COVID Vaccine Shot
- COVID-19 Vaccine: When Supply Outstrips Demand
- All Adults Now Eligible for COVID-19 Vaccine in US
- J&J Vaccine Pause a 'Recommendation' Not a 'Mandate'
- J&J COVID Vaccine Pause After Blood Clot Risk
- How Long Does COVID Vaccine Protection Last?
- If You've Had COVID, One Vaccine Jab Will Do
- Pfizer: COVID Vaccine Is Very Effective in Kids
- US Working on 'Vaccine Passport' Initiative
- States Race to Vaccinate Their Residents
- Can You Still Get COVID After Vaccination?
- Red Flags on AstraZeneca's COVID Vaccine Trial Data
- AstraZeneca COVID Vaccine Suspended by Several Countries
- One Year Into Pandemic, Biden Promises Vaccines for All U.S. Adults by May 1
- Most Employees Want COVID-19 Shot Before Returning to the Office
- Is a New Wave of COVID-19 Cases and Deaths on the Way?
- What's the Best COVID Vaccine?
- COVID Vaccines for All by End of May
- FDA Approves Third COVID Vaccine: Johnson & Johnson's Single-Shot
- Will All Americans Be Vaccinated by August?
- Will There Be Enough COVID Vaccine for All Americans By Summer?
- Are COVID Quarantines Necessary After Vaccination?
- Slow Vaccine Rollout Frustrates Most Americans
- Second Dose of COVID Vaccine Is Likely to Feel Worse
- U.S. Sees Continued Drop in New COVID Cases
- Pfizer Vaccine 90% Effective After First Dose
- COVID Vaccines Directly to U.S. Pharmacies
- Will Vaccines Protect You Against New COVID Variants?
- New J&J, Novavax COVID Vaccine Efficacy
- Nearly Half of Americans Want COVID Vaccine ASAP
- New Goal of 1.5 Million COVID Vaccinations a Day
- Details of National Pandemic Response Plan
- Once Nursing Home Residents Get a COVID Shot, Can Their Families Visit Them?
- Answering Your Questions on the COVID Vaccines
- Biden Says He Will Release All Vaccine Doses
- Will Vaccines Get Us Back to Normalcy by Summer?
- Allergists Offer Reassurance on COVID Vaccine Safety
- Are Two Full Doses of COVID Vaccine Needed?
- Ways to Speed COVID Vaccine Uptake
- 'Warp Speed' Vaccine Distribution Too Slow
- First 10 Days After COVID Hospital Discharge Risky
- FDA to Approve Moderna COVID Vaccine
- Can You Stop COVID Precautions After Vaccination?
- Rollout of Pfizer COVID Vaccine Begins in U.S.
Health Solutions From Our Sponsors

Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
https://emedicine.medscape.com/article/2500139-overview#a2
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html